Crossmark

Drug repurposing for coronavirus (COVID-19): <i>in silico</i> screening of known drugs against coronavirus 3CL hydrolase and protease enzymes

Crossref DOI link: https://doi.org/10.1080/07391102.2020.1758791

Published Online: 2020-04-26

Published Print: 2021-05-24

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Elmezayen, Ammar D. https://orcid.org/0000-0002-2926-7070
Al-Obaidi, Anas https://orcid.org/0000-0002-6089-8188
Şahin, Alp Tegin

Yelekçi, Kemal https://orcid.org/0000-0002-0052-4926
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tbsd20

Publication History

Received: 2020-04-03

Accepted: 2020-04-16

Published: 2020-04-26